Mature myelin maintenance requires Qki to coactivate PPARβ-RXRα-mediated lipid metabolism.

Lipid-rich myelin forms electrically insulating, axon-wrapping multilayers that are essential for neural function, and mature myelin is traditionally considered metabolically inert. Surprisingly, we discovered that mature myelin lipids undergo rapid turnover, and quaking (Qki) is a major regulator of myelin lipid homeostasis. Oligodendrocyte-specific Qki depletion, without affecting oligodendrocyte survival, resulted in rapid demyelination, within 1 week, and gradually neurological deficits in adult mice. Myelin lipids, especially the monounsaturated fatty acids and very-long-chain fatty acids, were dramatically reduced by Qki depletion, whereas the major myelin proteins remained intact, and the demyelinating phenotypes of Qki-depleted mice were alleviated by a high-fat diet. Mechanistically, Qki serves as a coactivator of the PPARβ-RXRα complex, which controls the transcription of lipid-metabolism genes, particularly those involved in fatty acid desaturation and elongation. Treatment of Qki-depleted mice with PPARβ/RXR agonists significantly alleviated neurological disability and extended survival durations. Furthermore, a subset of lesions from patients with primary progressive multiple sclerosis were characterized by preferential reductions in myelin lipid contents, activities of various lipid metabolism pathways, and expression level of QKI-5 in human oligodendrocytes. Together, our results demonstrate that continuous lipid synthesis is indispensable for mature myelin maintenance and highlight an underappreciated role of lipid metabolism in demyelinating diseases.

[1]  Matthew Grist,et al.  Remarkable Stability of Myelinating Oligodendrocytes in Mice , 2017, Cell reports.

[2]  J. Auwerx,et al.  PPARδ Promotes Running Endurance by Preserving Glucose. , 2017, Cell metabolism.

[3]  S. Amor,et al.  Multiple sclerosis animal models: a clinical and histopathological perspective , 2017, Brain pathology.

[4]  R. Verhaak,et al.  Qki deficiency maintains stemness of glioma stem cells in suboptimal environment by downregulating endolysosomal degradation , 2016, Nature Genetics.

[5]  Jeffrey L. Bennett,et al.  Loss of Myelin Basic Protein Function Triggers Myelin Breakdown in Models of Demyelinating Diseases , 2016, Cell reports.

[6]  S. Richard,et al.  Emerging functions of the Quaking RNA‐binding proteins and link to human diseases , 2016, Wiley interdisciplinary reviews. RNA.

[7]  S. Richard,et al.  Quaking Regulates Neurofascin 155 Expression for Myelin and Axoglial Junction Maintenance , 2016, The Journal of Neuroscience.

[8]  O. Stüve,et al.  Primary progressive multiple sclerosis—why we are failing , 2016, The Lancet.

[9]  S. Miller,et al.  Oligodendrocyte death results in immune-mediated CNS demyelination , 2015, Nature Neuroscience.

[10]  Gene W. Yeo,et al.  PPARδ repression in Huntington’s disease and its essential role in CNS translate into a potent agonist therapy , 2015, Nature Medicine.

[11]  Hans Lassmann,et al.  An updated histological classification system for multiple sclerosis lesions , 2016, Acta Neuropathologica.

[12]  Steven D. Miller,et al.  ER Chaperone BiP/GRP78 Is Required for Myelinating Cell Survival and Provides Protection during Experimental Autoimmune Encephalomyelitis , 2015, The Journal of Neuroscience.

[13]  F. Finkernagel,et al.  The transcriptional PPARβ/δ network in human macrophages defines a unique agonist-induced activation state , 2015, Nucleic acids research.

[14]  A. Ishii,et al.  Role of ERK1/2 MAPK Signaling in the Maintenance of Myelin and Axonal Integrity in the Adult CNS , 2014, The Journal of Neuroscience.

[15]  Samuel Bernard,et al.  Dynamics of Oligodendrocyte Generation and Myelination in the Human Brain , 2014, Cell.

[16]  B. Grygiel-Górniak Peroxisome proliferator-activated receptors and their ligands: nutritional and clinical implications – a review , 2014, Nutrition Journal.

[17]  John R. Yates,et al.  Identification of Long-Lived Proteins Reveals Exceptional Stability of Essential Cellular Structures , 2013, Cell.

[18]  Piotr Kozlowski,et al.  Diffusely Abnormal White Matter in Multiple Sclerosis: Further Histologic Studies Provide Evidence for a Primary Lipid Abnormality With Neurodegeneration , 2013, Journal of neuropathology and experimental neurology.

[19]  G. Hager,et al.  Analysis of the peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) cistrome reveals novel co-regulatory role of ATF4 , 2012, BMC Genomics.

[20]  T. Kilpatrick,et al.  Myelin Gene Regulatory Factor Is Required for Maintenance of Myelin and Mature Oligodendrocyte Identity in the Adult CNS , 2012, The Journal of Neuroscience.

[21]  Anthony Brown,et al.  FluoroMyelin™ Red is a bright, photostable and non-toxic fluorescent stain for live imaging of myelin , 2012, Journal of Neuroscience Methods.

[22]  I. Weissman,et al.  Janus-like opposing roles of CD47 in autoimmune brain inflammation in humans and mice , 2012, The Journal of experimental medicine.

[23]  Donald A. Wilson,et al.  ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models , 2012, Science.

[24]  B. Becher,et al.  Primary oligodendrocyte death does not elicit anti-CNS immunity , 2012, Nature Neuroscience.

[25]  K. Nave,et al.  Lipid metabolism in myelinating glial cells: lessons from human inherited disorders and mouse models , 2011, Journal of Lipid Research.

[26]  Jason I. Herschkowitz,et al.  The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo , 2011, Proceedings of the National Academy of Sciences.

[27]  H. Blöcker,et al.  Genomewide Analyses Define Different Modes of Transcriptional Regulation by Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) , 2011, PloS one.

[28]  S. Guan,et al.  Analysis of proteome dynamics in the mouse brain , 2010, Proceedings of the National Academy of Sciences.

[29]  Alan Peters,et al.  The Effects of Normal Aging on Myelinated Nerve Fibers in Monkey Central Nervous System , 2009, Front. Neuroanat..

[30]  Ryoichiro Kageyama,et al.  Roles of continuous neurogenesis in the structural and functional integrity of the adult forebrain , 2008, Nature Neuroscience.

[31]  S. Richard,et al.  New implications for the QUAKING RNA binding protein in human disease , 2008, Journal of neuroscience research.

[32]  Roland Martin,et al.  Multiple sclerosis: a complicated picture of autoimmunity , 2007, Nature Immunology.

[33]  K. Hirata,et al.  Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers , 2007, Glia.

[34]  Yue Feng,et al.  Rescuing qkv Dysmyelination by a Single Isoform of the Selective RNA-Binding Protein QKI , 2006, The Journal of Neuroscience.

[35]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[36]  G. Bartzokis Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease , 2004, Neurobiology of Aging.

[37]  S. Ando,et al.  Turnover of Myelin Lipids in Aging Brain , 2004, Neurochemical Research.

[38]  B. Popko,et al.  Inducible site‐specific recombination in myelinating cells , 2003, Genesis.

[39]  S. Richard,et al.  Nuclear Retention of MBP mRNAs in the Quaking Viable Mice , 2002, Neuron.

[40]  R. Evans,et al.  Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[41]  G. Bartzokis,et al.  Age-related changes in frontal and temporal lobe volumes in men: a magnetic resonance imaging study. , 2001, Archives of general psychiatry.

[42]  C. Lucchinetti,et al.  Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy. , 2001, Trends in molecular medicine.

[43]  Yue Feng,et al.  Destabilization and Mislocalization of Myelin Basic Protein mRNAs in quaking Dysmyelination Lacking the QKI RNA-Binding Proteins , 2000, The Journal of Neuroscience.

[44]  J. Ward,et al.  Growth, Adipose, Brain, and Skin Alterations Resulting from Targeted Disruption of the Mouse Peroxisome Proliferator-Activated Receptor β(δ) , 2000, Molecular and Cellular Biology.

[45]  B. Scheithauer,et al.  A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. , 1999, Brain : a journal of neurology.

[46]  J. Trimmer,et al.  Dependence of Nodal Sodium Channel Clustering on Paranodal Axoglial Contact in the Developing CNS , 1999, The Journal of Neuroscience.

[47]  P. Mcgeer,et al.  Myelin degeneration in multiple system atrophy detected by unique antibodies. , 1998, The American journal of pathology.

[48]  T. Pineau,et al.  Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators , 1995, Molecular and cellular biology.

[49]  K. Jellinger,et al.  Patterns of oligodendroglia pathology in multiple sclerosis. , 1994, Brain : a journal of neurology.

[50]  W. Brück,et al.  Oligodendrocytes in the early course of multiple sclerosis , 1994, Annals of neurology.

[51]  R. Ledeen,et al.  Long‐chain acyl‐coenzyme a synthetase in rat brain myelin , 1987, Journal of neuroscience research.

[52]  A. D. Smith,et al.  The modification of mammalian membrane polyunsaturated fatty acid composition in relation to membrane fluidity and function. , 1984, Biochimica et biophysica acta.

[53]  O. Koul,et al.  UDP-galactose-ceramide galactosyltransferase in rat brain myelin subfractions during development. , 1980, The Biochemical journal.

[54]  N. Baumann,et al.  LIPID COMPOSITION OF QUAKING MOUSE MYELIN: COMPARISON WITH NORMAL MOUSE MYELIN IN THE ADULT AND DURING DEVELOPMENT 1 , 1973, Journal of neurochemistry.

[55]  M. Smith,et al.  The turnover of myelin in the adult rat. , 1968, Biochimica et biophysica acta.

[56]  N. Baumann,et al.  Fatty acid and lipid composition of the brain of a myelin deficient mutant, the "quaking" mouse. , 1968, European journal of biochemistry.

[57]  R. Sidman,et al.  Mutant Mice (Quaking and Jimpy) with Deficient Myelination in the Central Nervous System , 1964, Science.